Immunomedics (IMMU) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Immunomedics (IMMU) Misses Q3 EPS by 2c

Jefferies Upgrades Immunomedics (IMMU) to Buy

May 6, 2016 7:53 AM EDT

Jefferies upgraded Immunomedics (NASDAQ: IMMU) from Hold to Buy with a price target of $5.00 (from $1.50) as '132 continues to impress.

Analyst Chris Howerton, PhD commented, "In our view, '132 continues to demonstrate impressive clinical data in solid tumors. In particular, the recent... More

Immunomedics' (IMMU) IMMU-132 in TNBC Abstract Selected for Best of ASCO Program

May 2, 2016 12:18 PM EDT

Immunomedics, Inc., (Nasdaq: IMMU) announced that the abstract on... More